VICORE PHARMA HOLDING AB ADR
VCRE · NASDAQ
Updated at 2026-10-13 11:47:56
- Today's High
- --
- Today’s Low
- --
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $9.06
- Previous Close
- $9.23
- Volume
- 43.54K
- Market Cap
- $2.53B
- P/E Ratio
- --
- EPS
- $-1.91
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- KORNHAMNSTORG 53, STOCKHOLM, SWEDEN, 111 27
- Country
- SE
- Listing Date
- 2015-12-10
- Fiscal Year End
- December
- Shares Outstanding
- 281.53M
- CIK
- --
- Website
- vicorepharma.com
Vicore Pharma Holding AB (publ), a clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden. The company is headquartered in Stockholm, Sweden.
Financial Metrics
Revenue
2026-06-30
$2.21M
2026-03-31
$602K
2025-12-31
$419K
2025-06-30
$1.74M
Operating Expenses
2026-06-30
$152.31M
2026-03-31
$124.44M
2025-12-31
$134.12M
2025-06-30
$112.91M
Net Income
2026-06-30
-$142.84M
2026-03-31
-$108.61M
2025-12-31
-$137.1M
2025-06-30
-$115.36M
Net Profit Margin
2026-06-30
-6.45K%
2026-03-31
-18.04K%
2025-12-31
-32.72K%
2025-06-30
-6.6K%
Earnings Per Share
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-06-30
--
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$142.67M
2026-03-31
-$107.88M
2025-12-31
-$128.55M
2025-06-30
-$100.86M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-06-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 |
|---|---|---|---|---|
| Revenue | $2.21M | $602K | $419K | $1.74M |
| Operating Expenses | $152.31M | $124.44M | $134.12M | $112.91M |
| Net Income | -$142.84M | -$108.61M | -$137.1M | -$115.36M |
| Net Profit Margin | -6.45K% | -18.04K% | -32.72K% | -6.6K% |
| Earnings Per Share | -- | -- | -- | -- |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$142.67M | -$107.88M | -$128.55M | -$100.86M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.